Pharmaceutical impurities Offered | |||
S.No | Impurity Name | IUPAC NAME | CAS No |
I: Quetiapine Fumarate Impurities | |||
1 | EP Impurity-A | 2-[2-(4-Dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethyl acetate | 844639-07-2 |
2 | EP Impurity-B | 11-(Piperazin-1-yl)dibenzo [b,f][1,4]thiazepine.HCl | 111974-74-4 |
3 | EP Impurity-C | 2-(2-(4-(Dibenzo[b,f][1,4] thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl) piperazin | 1798840-31-9 |
4 | EP Impurity-D | 1,4-Bis(dibenzo[b,f][1,4] thiazepin-11-yl)piperazine -1-yl)acetate | 945668-94-0 |
5 | EP Impurity-E | 1,2-bis[2-(4-Dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethane | 1371638-05-9 |
6 | EP Impurity-F | (2-((2-Aminophenyl)thio) phenyl) (4-(2-(2-hydroxy ethoxy)ethyl)piperazin-1-yl) methanone | 848814-27-7 |
7 | EP Impurity-G | Dibenzo-(1,4)-thiazepine-11(10H)-One | 3159-07-7 |
8 | EP Impurity-H | 2-[2-(4-Dibenzo[b,f][1,4] thiazepin-11-yl-piperazin-1-yl-1-oxide)ethoxy]ethanol | 1076199-40-0 |
9 | EP Impurity-I | 2-[4-(Dibenzo[b,f][1,4] thiazepin-11-yl)piperazin-1-1yl]ethanol.HCl | 329218-14-6 |
10 | EP Impurity-J | 2-[2-(2-{2-[4-(Dibenzo[b,f] [1,4]thiazepin-11-yl)piperazin -1-yl]ethoxy}ethoxy)ethoxy] ethanol | 1356906-17-6 |
11 | EP Impurity-K | N-(2-((2-(4-(2-(2-Hydroxy ethoxy)ethyl)piperazine-1-carbonyl)phenyl) thio) phenyl)acetamide HCl | 1371638-10-6 |
12 | EP Impurity-L | 2-(2-(4-(9-Chlorodibenzo[b,f] [1,4]thiazepin-11-yl)piperazin -1-yl)ethoxy) ethanol | 1371638-11-7 |
13 | EP Impurity-N | 4-[2-[2-(4-Dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethyl]-1-[(2-hydroxyethoxyl)ethyl]-piperazine(U/D) | 1800291-86-4 |
14 | EP Impurity-O | 11-(4-(2-(2-(Trityloxy)ethoxy) ethyl)piperazin-1-yl)dibenzo [b,f][1,4]thiazepine | 844639-06-1 |
15 | EP Impurity-P | 11-(4-Ethylpiperazin-1-yl) dibenzo[b,f][1,4]thiazepineHCl | 1011758-03-4 |
16 | EP Impurity-Q | 4-(Dibenzo[b,f][1,4] thiazepin-11-yl)-1,1-bis[2-(2-hydroxy ethoxy) ethyl]piperazin-1-ium | N/A |
17 | EP Impurity-R | (E)-4-Ethoxy-4-oxobut-2-enoic acid | 2459-05-4 |
18 | EP Impurity-S | 2-[2-[4-(5-Oxidodibenzo [b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]ethanol HCl | 329216-63-9 |
19 | EP Impurity-T | 4-(Dibenzo[b,f][1,4]thiazepin-11-yl)morpholine | 5747-46-6 |
20 | EP Impurity-U | Dibenzo[b,f][1,4]thiazepin-11-amine(U/D) | 5786-26-5 |
21 | EP Impurity-V | 2-(2-(4-(Phenanthridin-6-yl)piperazin-1-yl)ethoxy) ethanol | N/A(U/D) |
22 | EP Impurity-w | 11-(2-(2-(4-(Dibenzo[b,f][1,4] thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy) dibenzo [b,f][1,4]thiazepine | 1800608-95-0 |
23 | HEEP Impurity | 1-[2-(2-Hydroxyethoxy) ethyl]piperazine | 13349-82-1 |
II: ES-Omeprazole Impurities | |||
24 | EP Impurity-A | 5-methoxy-1H-benzo[d]imidazole-2-thiol | 37052-78-1 |
25 | EP Impurity-B | 2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole | 110374-16-8 |
26 | EP Impurity-C | 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl) methyl) thio)-1H-benzo [d]imidazole. | 73590-85-9 |
27 | EP Impurity-D | 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl) methyl)sulfonyl)-1H-benzo [d]imidazole | 88546-55-8 |
28 | EP Impurity-E | 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridine 1-oxide | 176219-04-8 |
29 | EP Impurity F&G Mixture | 1,3-Dimethyl-8-methoxy-12-thioxopyrido[1′,2′:3,4]imidazo[1,2-a]benzimidazol-2(12H)-one and 1,3- Dimethyl-9-methoxy-12-thioxopyrido[1′,2′:3,4]imidazo[1,2-a]benzimidazol-2(12H)-one Mixture | 125656-82-8 & 125656-83-9 |
30 | EP Impurity-H | 2-(((4-chloro-3,5-dimethyl pyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d] imidazole | 863029-89-4 |
31 | EP Impurity-I | 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3,5-dimethylpyridine 1-oxide | 158812-85-2 |
32 | Chloro Impurity | 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine HCl | 86604-75-3 |
33 | Es-Omeprazole impurity at 0.25 RRT | 1-(5-methoxy-1H-benzo [d] imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid | 1227380-90-6 |
III: Aspirin Impurities | |||
34 | 4-Hydroxy benzoic acid | 99-96-7 | |
35 | 4-Hydroxy Isopthalic acid | 636-46-4 | |
36 | 2-Hydroxy benzoic acid | 69-72-7 | |
37 | 2-((2-Acetoxybenzoyl)oxy) benzoic acid | 530-75-6 | |
38 | 2-((2-Hydroxybenzoyl)oxy) benzoic acid | 552-94-3 | |
39 | 2-Acetoxybenzoic anhydride | 1466-82-6 | |
IV: Dipyridamole Impurities | |||
40 | EP-Impurity-A | 2,2′-[[4,6,8-Tri(piperidin-1-yl)pyrimido [5,4-d] pyrimidin-2-yl] nitrilo]diethanoL | 16982-40-4 |
41 | EP-Impurity-B | 2,2′,2″,2”’,2””,2””’-[[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl] trinitrilo] hexaethanol | 16908-47-7 |
42 | EP-Impurity-C | 2,2′-[[6-Chloro-4,8-di (pipe ridin-1-yl)pyrimido[5,4-d] pyrimidin-2-yl]nitrilo]diethanol | 54093-92-4 |
43 | EP-Impurity-D | 2,2′-[[6-(2-Hydroxyethyl) amino-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]nitrilo]diethanol | 1176886-12-6 |
44 | EP-Impurity-E | 2,2′,2”,2’’’-[[6,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl] dinitrilo]tetraethanol (U/D) | N/A |
45 | EP-Impurity-F | 2,2′,2”,2’’’-[[4-[(2-hydroxy ethyl)amino]-8-(piperidin-1-yl)-pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo]tetraethanol (U/D) | 60286-30-8 |
46 | EP-Impurity-G | 6-Dichloro-4,8-di(piperidin-1-yl)-pyrimido[5,4-d]pyrimidine | 7139-02-8 |
V: Metoprolol Impurities | |||
47 | EP-impurity-A | (2RS)-1-(Ethylamino)-3-[4-(2-methoxyethyl)phenoxy] propan-2-ol | 109632-08-8 |
48 | EP-impurity-B | 4-(2-Methoxyethyl)phenol | 56718-71-9 |
49 | USP-impurity-B | (+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl) phenoxy]-propane | 56718-76-4 |
50 | EP-impurity-C | 4-[2-Hydroxy-3-(1-methyl ethyl)aminopropoxy]benzaldehyde | 29122-74-5 |
51 | EP-impurity-O | (±)-N,N-Bis[2-hydroxy-3-[4-(2-methoxyethyl) phenoxy] propyl](1-methylethyl) amine. hydrochloride | 154784-36-8 |
VI: DiValoprex Sodium Impurities | |||
52 | Valeric acid | 109-52-4 | |
53 | 2-Methyl Valeric acid | 97-61-0 | |
54 | 2-Ethyl Valeric acid | 20225-24-5 | |
55 | 2-Butyl Valeric acid | N/A | |
56 | 2-Isopropyl Valeric acid | 62391-99-5 | |
57 | Methyl Valproate | 22632-59-3 | |
VII: Ondansetron Impurities | |||
58 | EP Impurity-A | (3RS)-3-[(dimethylamino) methyl]-9-methyl-1,2,3,9-tetra hydro-4Hcarbazol-4-one.HCl | 119812-29-2 |
59 | EP Impurity-C | 9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | 27387-31-1 |
60 | EP Impurity-D | 9-methyl-3-methylene-1,2,3,9-tetrahydro- carbazol-4-4H- one | 99614-64-9 |
61 | EP Impurity-E | 1H-Imidazole | 288-32-4 |
62 | EP Impurity-F | 2-Methyl-1H-imidazole | 693-98-1 |
63 | EP Impurity-G | (3RS)-3-[(1H-Imidazol-1-yl)methyl]-9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | N/A |
64 | EP Impurity-H | (3RS)-3-[(2-Methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one | 9614-14-9 |
VIII: Aripiprazole Impurities | |||
65 | EP Impurity-A | 7-Hydroxy-3,4-dihydro quinolin-2(1H)-one | 22246-18-0 |
66 | EP Impurity-B | 1-(2,3-Dichlorophenyl) piperazine hydrochloride | 119532-26-2 |
67 | EP Impurity-C | 7-[4-[4-(2-Chlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone | 203395-81-7 |
68 | EP Impurity-D | 7-[4-[4-(3-Chlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone | 203395-82-8 |
69 | EP Impurity-E | 7-(4-(4-(2,3-dichlorophenyl) piperazin-1-yl)butoxy)-3,4-quinolin-2(1H)-one | 129722-25-4 |
70 | EP Impurity-F | 4-(2,3-Dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydro quinolin-7-yloxy)butyl] piperazine-1-oxide | 573691-09-5 |
71 | EP Impurity-G | 1,1′-(Ethane-1,1-diyl)bis(2,3-dichloro-4{4-[3,4-dihydro quin olin-2(1H)-one-7-yloxy butyl] piperazin-1-yl}benzene)(U/D) | 1797986-18-5 (Under deve lopment) |
72 | 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one | N/A | |
73 | USP RC-B | 7-(4-Hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one | 889443-20-3 |
74 | 7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one | 129722-34-5 | |
75 | 7,7′-[Butane-1,4,diylbis(oxy) ]bis[3,4-dihydroquinolin-2 (1H) -one | 882880-12-8 | |
76 | 1-(3,4-Dichloro phenyl) piperazine.HCl | 76835-17-1 | |
77 | 7-Hydroxyquinolin-2(1H)-one | 70500-72-0 | |
78 | Aripiprazole 3,4-Dichloro Analouge | ||
IX: Riluzole Impurities | |||
79 | 5-(Trifluoromethoxy) benzo(d)Thiazol-2-amine | N/A | |
80 | 4-(Trifluoromethoxy ) benzo(d)Thiazol-2-amine | N/A | |
81 | 4-Trifluoromethoxyaniline | 461-82-5 | |
82 | 2,6-dibromo-4-(Trifluoromethoxy)aniline | 88149-49-9 | |
83 | 4-bromo-6-(Trifluoromethoxy)-2-benzothiazolamine | 144631-82-3 | |
X: Lansoprazole | |||
84 | EP Impurity-A | 2-[[[3-Methyl-1-oxido-4-(2,2 ,2-trifluoroethoxy)-2-pyridinyl] methyl]sulfinyl]-1H benz imidazole | 213476-12-1 |
85 | EP Impurity- B | 2-[[[3-Methyl-4-(2,2,2-tri fluo ro ethoxy)-2-pyridinyl] methyl ]sulfonyl]-1H-benz imidazole | 131926-99-3 |
86 | EP Impurity- C | 2-[[[3-Methyl-4-(2,2,2-tri fluor oethoxy)-2-pyridinyl] methyl] sulfanyl]-1H-benz imidazole | 103577-40-8 |
87 | EP Impurity-D | 1H-Benzimidazol-2-ol ; 2-Hydroxybenzimidazole | 615-16-7 |
88 | EP Impurity-E | 2-Mercaptobenzimidazole | 583-39-1 |
89 | EP Impurity-F | 2-[(RS)-[(4-Chloro-3-methyl pyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole | 168167-42-8 |
90 | Sulphone-N-Oxide | 2-[[[3-Methyl-1-oxido-4-(2,2, 2 -trifluoroethoxy)-2-pyridinyl] methyl]sulfonyl]-1H-benz imidazole | 953787-54-7 |
91 | Sulphide-N-Oxide | 2-[[[3-Methyl-1-oxido-4-(2,2 ,2-trifluoroethoxy)-2-pyridinyl] methyl]sulfanyl]-1H-benz imidazole | 163119-30-0 |
92 | S-Isomer | 2-[(S)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl] methyl]sulfinyl]-1H-benz imidazole | 138530-95-7 |
93 | Chloro Impurity | 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride | 127337-60-4 |
XI: Rabeprazole Sodium | |||
94 | EP Impurity-A | 2-[[4-(3-Methoxypropoxy)-3-methyl-pyridin-2-yl]methyl sulfonyl]benzoimidazole | 117976-47-3 |
95 | EP Impurity-B | 2-[[4-(3-Methoxypropoxy)-3-methyl-pyridin-2-yl]methyl sulfanyl]benzoimidazole | 117977-21-6 |
96 | EP Impurity-C | 1-(1H-Benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydro pyri dine-2-carboxylic acid (U/D) | 1163685-30-0 |
97 | EP Impurity-D | 2-[[[1-Oxide-4-(3-methoxy propoxy)-3-methyl-2-pyri dinyl] methyl]sulfinyl]-1H-benzimidazole | 924663-38-7 |
98 | EP Impurity-E | 2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole | 924663-38-7 |
99 | EP Impurity-F | 2-Mercaptobenzimidazole | 583-39-1 |
100 | EP Impurity-G | 2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole | 102804-82-0 |
101 | EP Impurity-H | 2-[(RS)-[(4-Chloro-3-methylpyridin-2-yl)methyl] sulphinyl]-1H-benzimidazole; | 168167-42-8 |
102 | EP Impurity-I | 2-[[[1-Oxide-4-(3-methoxy propoxy)-3-methyl-2-pyri dinyl] methyl]sulfonyl]-1H-benzimidazole | 924663-37-6 |
103 | EP Impurity-K | 2-Hydroxybenzimidazole | 615-16-7 |
104 | (S)-Isomer | Sodium (S)-2-[[4-(3-methoxy propoxy)-3-methyl-pyridin-2-yl]methylsulfinyl] benz imidazole | 171440-19-0 |
105 | Chloro impurity | 2-Chloromethyl-3-methyl-4-(3-methoxypropoxy)pyridine hydrochloride | 153259-31-5 |
106 | EP Impurity-H Sulfide | 2-[(RS)-[(4-Chloro-3-methylpyridin-2-yl) methyl] sulphinyl]-1H-benzimidazole | 103312-62-5 |
XII: Paliperidone | |||
107 | USP Impurity-A | 3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a]pyrimidin-4-one hydrochloride | 849727-64-6 |
108 | USP Impurity-B | 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride | 84163-13-3 |
109 | USP Impurity-C | 3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-a)-pyrimidin-4-one | 130049-82-0 |
110 | USP Impurity-D | 3-{2-[4-(6-Fluoro-1,2-benz isoxazol-3-yl) piperidin-1-yl] ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a]pyrimidin-4-one N-oxide | 761460-08-6 |
111 | 9-Keto Impurity | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione | 1189516-65-1 |
XII: Pantoprazole Impurities | |||
112 | EP Impurity-A | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl ]sulfonyl]-1H-benzimidazole | 127780-16-9 |
113 | EP Impurity-B | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl ]thio]-1H-benzimidazole | 102625-64-9 |
114 | EP Impurity-C | 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole | 97963-62-7 |
115 | EP Impurity-D&F Mix | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl ]sulfinyl]-1-methyl -1H-benz imidazole & 6-(Difluoro methoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl]sulfinyl]-1-methyl -1H-benzimidazole | 624742-53-6 & 721924-06-7 |
116 | N-oxide Impurity | 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl] sulfinyl} benzimidazol-1-ide N-oxide | 953787-60-5 |
117 | Sulphone-N-Oxide | 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl] sulfonyl} benzimidazol-1-ide N-oxide | 953787-55-8 |
118 | Chloro impurity | 2-(Chloromethyl)-3,4-dimethoxy pyridinium hydrochloride | 72830-09-2 |
XIV: Duloxetine Impurities | |||
119 | EP Impurity-A | (3R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine HCl | 910138-96-4 (HCl Salt) |
120 | EP Impurity-B | (1S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol | 116539-55-0 |
121 | EP Impurity-C | 4-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl] naphthalen-1-ol.HCl | 949096-01-9 (HBr Salt) (U/D) |
122 | EP Impurity-D | Naphthalen-1-ol | 90-15-3 |
123 | EP Impurity-E | 2-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl] naphthalen-1-ol | 1033719-36-6 (HCl salt) (U/D) |
124 | EP Impurity-F | (3S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine.HCl(U/D) | 1104890-90-5 (HCl salt) |
125 | EP Impurity-G | 1-Fluoronaphthalene | 321-38-0 |
126 | USP RC -H | (S)-4-(Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl) propyl] amino)-4-oxo buta noic acid ; (S)-Duloxetine Succinamide | 199191-66-7 |
XV: Sitagliptin Impurities | |||
127 | EP Impurity-A | (S)-4-Oxo-4-[3-(trifluoro methyl)-5,6-dihydro [1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl) butan-2-amine phosphate; (S)-Sitagliptin Isomer | |
128 | EP Impurity-B | (R)-4-Oxo-4-[3-(trifluoro methyl)-5,6-dihydro[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,5-difluoro phenyl) butan-2-amine phosphate; Sitagliptin 4-Desfluoro Impurity | 1345822-87-8.(U/D) |
129 | EP Impurity-C | (R)-4-Oxo-4-[3-(trifluoro methyl)-5,6-dihydro[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4-difluoro phenyl) butan-2-amine phosphate; Sitagliptin 5-Desfluoro Impurity | 1345822-86-7.(U/D) |
120 | Sitagliptin FP Impurity-E | (3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | 936630-57-8 |
131 | Sitagliptin Triazole.HCl | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 |
XVI: Lacosamide Impurities | |||
132 | N-Methyl Lacosamide | 2-acetamido-N-benzyl-3-methoxy-N-methyl propanamide | |
133 | Desacetyl Desmethyl Lacosamide | 2-amino-N-benzyl-3-hydroxypropanamide | 175481-39-7 |
134 | N-Desacetyl Lacosamide HCl | 2-amino-N-benzyl-3-methoxypropanamide hydrochloride | 196601-69-1 |
135 | N-acetyl O-methyl L-serine methyl ester:- | methyl 2-acetamido-3-methoxypropanoate | |
XVII: Furosemide Impurities | |||
136 | Furosemide Impurity-A | 2-Chloro-4-[(furan-2-yl methyl) amino]-5-sulfamoylbenzoic acid | 4818-59-1 |
1347 | Furosemide Impurity-B | 2,4-Dichloro-5-sulfamoylbenzoic Acid | 2736-23-4 |
138 | Furosemide Impurity-C | 2-Amino-4-chloro-5-sulfamoylbenzoic acid | 3086-91-7 |
139 | Furosemide Impurity-D | 2,4-Bis[(Furan-2-ylmethyl) amino]-5-sulfamoylbenzoic acid | 5046-19-5 |
140 | Furosemiiide Impurity-E | 2,4-Dichlorobenzoic acid | 50-84-0 |
141 | Furosemide Impurity-F | 4-Chloro-5-sulfamoyl-2-[[(( 2RS)-tetrahydrofuran-2-yl) methyl]amino]benzoic acid | 4793-38-8 |
XVIII: ITRACONAZOLE Impurities | |||
142 | EP Impurity-A | 4-[4-[4-(4-Methoxyphenyl) piperazin-1-yl]phenyl]-2-[(1 RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 252964-68-4 |
143 | EP Impurity-B | 4-[4-[4-[4-[[cis-2-(2,4-Di chl orophenyl)-2-(4H-1,2,4-tria zol-4-ylmethyl)-1,3-dioxolan -4-yl]methoxy]phenyl] pipera zin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 854372-77-3 |
144 | EP Impurity-C | 4-[4-[4-[4-[[cis-2-(2,4-Dichlo rophenyl)-2-(1H-1,2,4-triazol -1-ylmethyl)-1,3-dioxolan-4-yl]methoxyphenyl]piperazin-1-yl]phenyl]-2-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one | 74855-91-7 |
145 | EP Impurity-D | 4-[4-[4-[4-[[cis-2-(2,4-Dichlo rophenyl)-2-(1H-1,2,4-triazol -1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1-methyleth yl)-2,4-dihydro-3H-1,2,4-triazol-3-one | 89848-49-7 |
146 | EP Impurity-E | 4-[4-[4-[4-[[trans-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 252964-65-1 |
147 | EP Impurity-F | 2-Butyl-4-[4-[4-[4-[[cis-2-(2, 4-dichlorophenyl)-2-(1H-1, 2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy] phe nyl]piperazin-1-yl]phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 89848-51-1 |
XIX: RANOLAZINE Impurities | |||
148 | USP Related
Compound-A |
1-(2,3-Epoxypropoxy)-2-methoxybenzene | 2210-74-4 |
149 | USP Related
Compound-B |
N-(2,6-Dimethylphenyl)-4-(2 -hydroxy-3-phenoxypropyl)-1-piperazineacetamide | 755711-09-2 |
150 | USP Related
Compound-C |
N-(2,6-Dimethylphenyl)-1-piperazineacetamide | 5294-61-1 |
151 | USP Related
Compound-D |
N,N’-bis(2,6-Dimethyl phe nyl)-1,4-piperazine di acetamide | 380204-72-8 |
XX: Ziprasidone Impurities | |||
152 | (ziprasidone compound B | 6-chloro-5-(2-chloro-1-hydroxyethyl)indolin-2-one | |
153 | ziprasidone compound C | 6-chloroindolin-2-one |